Developer docs
API playgroundTry for free, no card

Search company profiles

Natural Alternatives International

Full company profile

uuid000cbgr

Namestring
Natural Alternatives International
Legal namestring
Natural Alternatives International, Inc.
Websiteurl
nai-online.com
Company typeenum
Public
Founded yearint
1980
Descriptiontext

Natural Alternatives International (NAI), founded in 1980 by Mark LeDoux and headquartered in Carlsbad, California, is a publicly traded nutritional supplement contract manufacturer (NASDAQ: NAII) operating across facilities in Vista, California (160,000 sq ft) and Manno, Switzerland (100,000 sq ft, via the wholly owned NAIE subsidiary). The company runs a vertically integrated production platform that spans custom formulation, manufacturing, quality assurance testing, stability programs, materials receiving, weighing and blending, warehousing, and finished goods packaging. The Carlsbad headquarters includes a state-of-the-art 54,154 sq ft high-volume powder blending and packaging facility commissioned in 2023, with annual capacity exceeding 26 million pounds of powder and nearly 100,000 sq ft of climate-controlled storage supporting outputs of approximately 2 billion capsules, 2 billion tablets, and 26 million pounds of powder per year. The company holds an unusually dense certification stack including cGMP, FDA registration, Health Canada GMP, NSF GMP and Sport, SSCI (first company certified in May 2021), SwissMedic GMP, Informed Sport, Organic NFC, Halal, and Kosher, with dedicated Client Success Managers overseeing enterprise B2B customers on minimum order quantities of 10,000 bottles or bags and distribution reaching 40+ countries.

The business operates two revenue streams: private-label contract manufacturing for supplement brands (approximately $102.7M of $108.0M, or 84%, of net sales in 9-month FY2026) and CarnoSyn® Brands, a proprietary portfolio of patented beta-alanine ingredients (CarnoSyn® instant-release, SR CarnoSyn® sustained-release, CarnoSyn® 4X, and TriBsyn® carnosine booster) generating royalty, licensing, and raw material sales ($5.3M in 9-month FY2026). The CarnoSyn® platform is the only beta-alanine with FDA New Dietary Ingredient (NDI) status and is supported by 35+ global patents and more than 55 clinical studies; SR CarnoSyn® received Self-Affirmed GRAS in 2017 and CarnoSyn® in 2019. FY2025 net sales of $129.9M grew 14% from $113.8M, and growth has accelerated to 23% in Q3 FY2026 ($35.5M), although a 9-month FY2026 net loss of $7.2M has been attributed to underutilization of factory capacity.

Go-to-market is direct B2B enterprise field sales complemented by distribution partnerships (B&D Nutritional Ingredients in the US since September 2024, Barentz for Brazil) and channel presence at industry events such as SupplySide West plus scientific conferences (ISSN, ESPEN, ACSM). Recent strategic actions include the April 2026 launch of patent-pending CarnoSyn® 4X, the May 2026 expansion of TriBsyn® into ready-to-drink beverages, gummies, dairy, and medical nutrition, the May 2026 closing of a $31 million credit facility with Legacy Corporate Lending that replaced a Wells Fargo line after a Q1 FY2025 covenant breach, and CEO Mark LeDoux's May 2026 assumption of Managing Director duties at NAIE alongside a salary reduction.

Short descriptiontext

Natural Alternatives International is a publicly traded nutritional supplement contract manufacturer (NASDAQ: NAII) that formulates, produces, and packages private-label supplements for brands across 40+ countries and licenses its proprietary CarnoSyn® beta-alanine ingredient platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract supplement manufacturing, nutritional supplement formulation, beta-alanine ingredients, private-label supplements, sports nutrition ingredients
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
Product category
Nutritional Supplement Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Private-label contract manufacturing
TypeOne Time License
Description

Custom formulation, manufacturing, and packaging services for supplement brands. Production of capsules, tablets, and powders with minimum order quantities of 10,000 bottles or bags. Major revenue driver representing ~84% of net sales ($102.7M of $108.0M in 9-months FY2026).

nai-online.com
2CarnoSyn® beta-alanine royalties, licensing and raw materials
TypeLicensing Royalties
Description

Patent licensing, trademark royalties, and raw material sales for proprietary beta-alanine ingredients (CarnoSyn®, SR CarnoSyn®, CarnoSyn® 4X, TriBsyn®). Revenue decreased 11% to $5.3M in first nine months of FY2026.

nai-online.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom contract manufacturing MOQ 10,000 units
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Minimum order quantity of 10,000 bottles or bags for high-volume production runs

nai-online.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1CarnoSyn Brands
Description

Portfolio of patented beta-alanine ingredients including CarnoSyn instant-release, SR CarnoSyn sustained-release, CarnoSyn 4X high-bioavailability, and TriBsyn carnosine booster products

nai-online.com
+4 more records
Core offering1 text field

Natural Alternatives International (NAI) is a custom contract manufacturer of nutritional supplements, providing formulation, manufacturing, quality assurance testing, packaging, and warehousing services to supplement brands on a B2B basis with a 10,000-unit minimum order quantity. The company also develops, patents, and licenses its proprietary CarnoSyn® beta-alanine ingredient portfolio (instant-release powder, sustained-release tablets, CarnoSyn® 4X, TriBsyn®) to sports nutrition and wellness brands.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 4x bioavailability improvement with CarnoSyn® 4X vs standard beta-alanine
+2 more records
Product overview1 text field

Natural Alternatives International (NAI) operates as a nutritional supplement formulator and contract manufacturer offering a vertically integrated suite of services. The company's product portfolio centers on the proprietary CarnoSyn® Brands family of patented beta-alanine ingredients, including CarnoSyn® instant-release powder, SR CarnoSyn® sustained-release tablets, CarnoSyn® 4X high-bioavailability powder, and TriBsyn® carnosine booster. Complementing its proprietary ingredients, NAI provides comprehensive custom contract manufacturing services spanning custom formulation, manufacturing, QA testing, stability programs, warehousing, weighing and blending, and packaging. The company manufactures on two continents with facilities in Vista and Carlsbad, California and Manno, Switzerland, serving customers in 40 countries.

Product and service5 records
1CarnoSyn® Instant-Release Beta-Alanine Powder
CategoryProprietary ingredient
Description

The gold standard instant-release beta-alanine powder for sports nutrition and the only beta-alanine to achieve New Dietary Ingredient (NDI) status with the FDA. Backed by more than 55 clinical studies supporting endurance, recovery, mental focus, and lean muscle gains; supplied to supplement brands for incorporation into their products.

2SR CarnoSyn® Sustained-Release Beta-Alanine Tablets
CategoryProprietary ingredient
Description

Advanced tablet delivery form of beta-alanine with a sustained-release delivery system designed for everyday wellness and healthy aging. Received Self-Affirmed GRAS affirmation in 2017 and supports brain health, muscle health, heart health, systemic protection, and bone health with gradual, controlled release to avoid paresthesia.

3CarnoSyn® 4X Beta-Alanine Powder
CategoryProprietary ingredient
Description

Next-generation beta-alanine formulation delivering more than four times the bioavailability of standard beta-alanine without paresthesia (tingling sensation). Patent-pending proprietary ingredient optimized for sports nutrition and performance-focused users, supporting strength, endurance, and overall training capacity.

4TriBsyn® Carnosine Booster Powder
CategoryProprietary ingredient
Description

Paresthesia-free beta-alanine powder designed for daily wellness use with enhanced bioavailability and a low-dose, user-friendly format. Application footprint expanded in May 2026 into ready-to-drink beverages, protein drinks, dairy products, gummies, and medical nutrition formulations. Supports healthy aging, cognitive performance, and carnosine levels.

5Custom Contract Manufacturing Services
CategoryContract manufacturing service
Description

Full-service nutritional supplement contract manufacturing for private-label supplement brands, including custom formulation, high-volume production of capsules, tablets, and powders, in-house quality assurance testing, stability programs, materials receiving, climate-controlled warehousing, weighing and blending, and finished goods packaging. Minimum order quantity of 10,000 bottles or bags. Annual production capacity of over 2 billion capsules, 26 million pounds of powder, and 2 billion tablets.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-09-30
Description

U.S. distribution agreement for CarnoSyn® beta-alanine ingredient sales through B&D's established supplement industry distribution network.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive Brazilian distribution partnership for CarnoSyn® beta-alanine, expanding market reach in South America through Barentz's regional distribution capabilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multi-year exclusive manufacturing agreement for nutritional supplement products; longstanding partnership with extension announcements in recent years.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large-scale pharmaceutical and nutraceutical contract development and manufacturing organization (CDMO). Comparable to NAI as a CMO serving consumer health and supplement brands, but operates at vastly greater scale with a much broader softgel, oral dose and biologics portfolio rather than specializing in nutritional capsules/tablets/powders.

TypeBroad incumbent
Description

Global contract manufacturer with nutraceutical and oral dose capabilities serving supplement and consumer health brands. Comparable as a vertically integrated CMO with similar B2B model, but Lonza is diversified across pharma APIs, biologics and cell therapy and is not specialized in private-label sports nutrition or beta-alanine ingredients.

TypeDirect peer
Description

Ingredient and premix manufacturer serving sports nutrition and functional food brands, including competing beta-alanine and amino acid offerings sold to supplement companies. Directly comparable to NAI on the proprietary ingredient/licensing side, with comparable B2B distribution into supplement brands and similar end-customers.

TypeDirect peer
Description

Large-scale nutritional supplement manufacturer with its own brand portfolio plus private-label and bulk ingredient services. Comparable to NAI in vertical integration (own manufacturing, in-house QA, multiple certifications) and customer base (private-label supplement brands and direct retailers), though NOW is significantly larger and more retail-distribution-weighted.

TypeOthers
Description

Direct-selling nutrition and weight management company that outsources manufacturing to third-party CMOs. Comparable as a large consumer of private-label contract manufacturing services (a potential NAI customer archetype) and overlaps with NAI in sports nutrition, vitamins and meal replacement categories.

TypeDirect peer
Description

Vertically integrated whole-food nutritional supplement manufacturer with proprietary ingredients and in-house manufacturing facilities. Comparable to NAI on vertical integration, GMP manufacturing and proprietary ingredient differentiation, though Standard Process is focused on whole-food supplements rather than beta-alanine and sports nutrition.

TypeDirect peer
Description

Mid-size US nutritional supplement contract manufacturer offering custom formulation, manufacturing and packaging services to supplement brands. Most directly comparable peer to NAI's private-label CMO business model, with similar MOQ requirements, turnkey service offering and customer base of indie and mid-market supplement brands.

TypeEmerging player
Description

Scientifically positioned nutritional supplement company with proprietary formulations and contract manufacturing partnerships. Comparable to NAI in science-backed positioning and NSF/Sport-style certifications, but Thorne is a DTC brand rather than a CMO; NAI serves as a manufacturing partner to similar brand archetypes.

TypeDirect peer
Description

Specialty ingredient manufacturer with a portfolio that includes beta-alanine and amino-acid ingredients sold into sports nutrition and supplement brands. Directly comparable to NAI's CarnoSyn business as a competing supplier of beta-alanine raw materials to the same supplement brand customers.

TypeDirect peer
Description

Nutritional supplement contract manufacturer offering custom formulation, encapsulation, tableting and packaging. Comparable to NAI's CMO business in service offering, customer base (private-label supplement brands) and B2B go-to-market, though smaller and without a proprietary beta-alanine ingredient franchise.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Natural Alternatives International

Nutritional Supplement Manufacturingnai-online.com

Natural Alternatives International is a publicly traded nutritional supplement contract manufacturer (NASDAQ: NAII) that formulates, produces, and packages private-label supplements for brands across 40+ countries and licenses its proprietary CarnoSyn® beta-alanine ingredient platform.

What Natural Alternatives International does

Natural Alternatives International (NAI), founded in 1980 by Mark LeDoux and headquartered in Carlsbad, California, is a publicly traded nutritional supplement contract manufacturer (NASDAQ: NAII) operating across facilities in Vista, California (160,000 sq ft) and Manno, Switzerland (100,000 sq ft, via the wholly owned NAIE subsidiary). The company runs a vertically integrated production platform that spans custom formulation, manufacturing, quality assurance testing, stability programs, materials receiving, weighing and blending, warehousing, and finished goods packaging. The Carlsbad headquarters includes a state-of-the-art 54,154 sq ft high-volume powder blending and packaging facility commissioned in 2023, with annual capacity exceeding 26 million pounds of powder and nearly 100,000 sq ft of climate-controlled storage supporting outputs of approximately 2 billion capsules, 2 billion tablets, and 26 million pounds of powder per year. The company holds an unusually dense certification stack including cGMP, FDA registration, Health Canada GMP, NSF GMP and Sport, SSCI (first company certified in May 2021), SwissMedic GMP, Informed Sport, Organic NFC, Halal, and Kosher, with dedicated Client Success Managers overseeing enterprise B2B customers on minimum order quantities of 10,000 bottles or bags and distribution reaching 40+ countries.

The business operates two revenue streams: private-label contract manufacturing for supplement brands (approximately $102.7M of $108.0M, or 84%, of net sales in 9-month FY2026) and CarnoSyn® Brands, a proprietary portfolio of patented beta-alanine ingredients (CarnoSyn® instant-release, SR CarnoSyn® sustained-release, CarnoSyn® 4X, and TriBsyn® carnosine booster) generating royalty, licensing, and raw material sales ($5.3M in 9-month FY2026). The CarnoSyn® platform is the only beta-alanine with FDA New Dietary Ingredient (NDI) status and is supported by 35+ global patents and more than 55 clinical studies; SR CarnoSyn® received Self-Affirmed GRAS in 2017 and CarnoSyn® in 2019. FY2025 net sales of $129.9M grew 14% from $113.8M, and growth has accelerated to 23% in Q3 FY2026 ($35.5M), although a 9-month FY2026 net loss of $7.2M has been attributed to underutilization of factory capacity.

Go-to-market is direct B2B enterprise field sales complemented by distribution partnerships (B&D Nutritional Ingredients in the US since September 2024, Barentz for Brazil) and channel presence at industry events such as SupplySide West plus scientific conferences (ISSN, ESPEN, ACSM). Recent strategic actions include the April 2026 launch of patent-pending CarnoSyn® 4X, the May 2026 expansion of TriBsyn® into ready-to-drink beverages, gummies, dairy, and medical nutrition, the May 2026 closing of a $31 million credit facility with Legacy Corporate Lending that replaced a Wells Fargo line after a Q1 FY2025 covenant breach, and CEO Mark LeDoux's May 2026 assumption of Managing Director duties at NAIE alongside a salary reduction.

Natural Alternatives International firmographics

Firmographics
Name
Natural Alternatives International
Legal name
Natural Alternatives International, Inc.
Website
https://nai-online.com
Company type
Public
Founded year
1980
Operating status
Operating
Headcount range
51–100 employees
Short description
Natural Alternatives International is a publicly traded nutritional supplement contract manufacturer (NASDAQ: NAII) that formulates, produces, and packages private-label supplements for brands across 40+ countries and licenses its proprietary CarnoSyn® beta-alanine ingredient platform.
Ownership category
akta.pro rank

Where Natural Alternatives International is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Natural Alternatives International business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Private-label contract manufacturing: Custom formulation, manufacturing, and packaging services for supplement brands. Production of capsules, tablets, and powders with minimum order quantities of 10,000 bottles or bags. Major revenue driver representing ~84% of net sales ($102.7M of $108.0M in 9-months FY2026).
  2. CarnoSyn® beta-alanine royalties, licensing and raw materials: Patent licensing, trademark royalties, and raw material sales for proprietary beta-alanine ingredients (CarnoSyn®, SR CarnoSyn®, CarnoSyn® 4X, TriBsyn®). Revenue decreased 11% to $5.3M in first nine months of FY2026.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractCustom contract manufacturing MOQ 10,000 units

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Natural Alternatives International product offering

Product offering

Core offering

Natural Alternatives International (NAI) is a custom contract manufacturer of nutritional supplements, providing formulation, manufacturing, quality assurance testing, packaging, and warehousing services to supplement brands on a B2B basis with a 10,000-unit minimum order quantity. The company also develops, patents, and licenses its proprietary CarnoSyn® beta-alanine ingredient portfolio (instant-release powder, sustained-release tablets, CarnoSyn® 4X, TriBsyn®) to sports nutrition and wellness brands.

Product overview

Natural Alternatives International (NAI) operates as a nutritional supplement formulator and contract manufacturer offering a vertically integrated suite of services. The company's product portfolio centers on the proprietary CarnoSyn® Brands family of patented beta-alanine ingredients, including CarnoSyn® instant-release powder, SR CarnoSyn® sustained-release tablets, CarnoSyn® 4X high-bioavailability powder, and TriBsyn® carnosine booster. Complementing its proprietary ingredients, NAI provides comprehensive custom contract manufacturing services spanning custom formulation, manufacturing, QA testing, stability programs, warehousing, weighing and blending, and packaging. The company manufactures on two continents with facilities in Vista and Carlsbad, California and Manno, Switzerland, serving customers in 40 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • CarnoSyn Brands: Portfolio of patented beta-alanine ingredients including CarnoSyn instant-release, SR CarnoSyn sustained-release, CarnoSyn 4X high-bioavailability, and TriBsyn carnosine booster products
  • CarnoSyn
  • SR CarnoSyn
  • TriBsyn
  • CarnoSyn 4X

Products and services

  • CarnoSyn® Instant-Release Beta-Alanine Powder The gold standard instant-release beta-alanine powder for sports nutrition and the only beta-alanine to achieve New Dietary Ingredient (NDI) status with the FDA. Backed by more than 55 clinical studies supporting endurance, recovery, mental focus, and lean muscle gains; supplied to supplement brands for incorporation into their products.
  • SR CarnoSyn® Sustained-Release Beta-Alanine Tablets Advanced tablet delivery form of beta-alanine with a sustained-release delivery system designed for everyday wellness and healthy aging. Received Self-Affirmed GRAS affirmation in 2017 and supports brain health, muscle health, heart health, systemic protection, and bone health with gradual, controlled release to avoid paresthesia.
  • CarnoSyn® 4X Beta-Alanine Powder Next-generation beta-alanine formulation delivering more than four times the bioavailability of standard beta-alanine without paresthesia (tingling sensation). Patent-pending proprietary ingredient optimized for sports nutrition and performance-focused users, supporting strength, endurance, and overall training capacity.
  • TriBsyn® Carnosine Booster Powder Paresthesia-free beta-alanine powder designed for daily wellness use with enhanced bioavailability and a low-dose, user-friendly format. Application footprint expanded in May 2026 into ready-to-drink beverages, protein drinks, dairy products, gummies, and medical nutrition formulations. Supports healthy aging, cognitive performance, and carnosine levels.
  • Custom Contract Manufacturing Services Full-service nutritional supplement contract manufacturing for private-label supplement brands, including custom formulation, high-volume production of capsules, tablets, and powders, in-house quality assurance testing, stability programs, materials receiving, climate-controlled warehousing, weighing and blending, and finished goods packaging. Minimum order quantity of 10,000 bottles or bags. Annual production capacity of over 2 billion capsules, 26 million pounds of powder, and 2 billion tablets.

Quantifiable outcome

  • 4x bioavailability improvement with CarnoSyn® 4X vs standard beta-alanine
  • +2 more outcomes

Companies that use Natural Alternatives International

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Natural Alternatives International technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Natural Alternatives International partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • B&D Nutritional IngredientscoreChannel Partner/ Reseller/ Distributor · 30 September 2024U.S. distribution agreement for CarnoSyn® beta-alanine ingredient sales through B&D's established supplement industry distribution network.
  • BarentzcoreChannel Partner/ Reseller/ DistributorExclusive Brazilian distribution partnership for CarnoSyn® beta-alanine, expanding market reach in South America through Barentz's regional distribution capabilities.
  • The Juice Plus+® CompanycoreStrategic or Co-development PartnerMulti-year exclusive manufacturing agreement for nutritional supplement products; longstanding partnership with extension announcements in recent years.

Scale indicators7 records

Recent moves11 records

Expansion highlights5 records

Natural Alternatives International competitors and assessment

Company assessment

Broad incumbents

  • Catalent: Large-scale pharmaceutical and nutraceutical contract development and manufacturing organization (CDMO). Comparable to NAI as a CMO serving consumer health and supplement brands, but operates at vastly greater scale with a much broader softgel, oral dose and biologics portfolio rather than specializing in nutritional capsules/tablets/powders.
  • Lonza Group: Global contract manufacturer with nutraceutical and oral dose capabilities serving supplement and consumer health brands. Comparable as a vertically integrated CMO with similar B2B model, but Lonza is diversified across pharma APIs, biologics and cell therapy and is not specialized in private-label sports nutrition or beta-alanine ingredients.

Direct peers

  • Glanbia Nutritionals: Ingredient and premix manufacturer serving sports nutrition and functional food brands, including competing beta-alanine and amino acid offerings sold to supplement companies. Directly comparable to NAI on the proprietary ingredient/licensing side, with comparable B2B distribution into supplement brands and similar end-customers.
  • NOW Foods: Large-scale nutritional supplement manufacturer with its own brand portfolio plus private-label and bulk ingredient services. Comparable to NAI in vertical integration (own manufacturing, in-house QA, multiple certifications) and customer base (private-label supplement brands and direct retailers), though NOW is significantly larger and more retail-distribution-weighted.
  • Standard Process: Vertically integrated whole-food nutritional supplement manufacturer with proprietary ingredients and in-house manufacturing facilities. Comparable to NAI on vertical integration, GMP manufacturing and proprietary ingredient differentiation, though Standard Process is focused on whole-food supplements rather than beta-alanine and sports nutrition.
  • NutraScience Labs: Mid-size US nutritional supplement contract manufacturer offering custom formulation, manufacturing and packaging services to supplement brands. Most directly comparable peer to NAI's private-label CMO business model, with similar MOQ requirements, turnkey service offering and customer base of indie and mid-market supplement brands.
  • TSI Group: Specialty ingredient manufacturer with a portfolio that includes beta-alanine and amino-acid ingredients sold into sports nutrition and supplement brands. Directly comparable to NAI's CarnoSyn business as a competing supplier of beta-alanine raw materials to the same supplement brand customers.
  • Vitakem: Nutritional supplement contract manufacturer offering custom formulation, encapsulation, tableting and packaging. Comparable to NAI's CMO business in service offering, customer base (private-label supplement brands) and B2B go-to-market, though smaller and without a proprietary beta-alanine ingredient franchise.

Others

  • Herbalife: Direct-selling nutrition and weight management company that outsources manufacturing to third-party CMOs. Comparable as a large consumer of private-label contract manufacturing services (a potential NAI customer archetype) and overlaps with NAI in sports nutrition, vitamins and meal replacement categories.

Emerging players

  • Thorne HealthTech: Scientifically positioned nutritional supplement company with proprietary formulations and contract manufacturing partnerships. Comparable to NAI in science-backed positioning and NSF/Sport-style certifications, but Thorne is a DTC brand rather than a CMO; NAI serves as a manufacturing partner to similar brand archetypes.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Natural Alternatives International social profiles

Digital presence

Natural Alternatives International compliance and trust

Trust signal

Compliance11 records

Natural Alternatives International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Natural Alternatives International leadership team

Management profile

Number of profiles

Profiles6 records

Natural Alternatives International subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Natural Alternatives International funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Natural Alternatives International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Natural Alternatives International

What does Natural Alternatives International do?

Natural Alternatives International (NAI) is a custom contract manufacturer of nutritional supplements, providing formulation, manufacturing, quality assurance testing, packaging, and warehousing services to supplement brands on a B2B basis with a 10,000-unit minimum order quantity. The company also develops, patents, and licenses its proprietary CarnoSyn® beta-alanine ingredient portfolio (instant-release powder, sustained-release tablets, CarnoSyn® 4X, TriBsyn®) to sports nutrition and wellness brands.

Is Natural Alternatives International a public or private company?

Natural Alternatives International is a public company. It is classified as public and is currently operating.

When was Natural Alternatives International founded?

Natural Alternatives International was founded in 1980. It employs 51 to 100 people.

Where is Natural Alternatives International based?

Natural Alternatives International is headquartered in Carlsbad, United States, in the North America region.

How does Natural Alternatives International make money?

Two revenue lines are on record. Private-label contract manufacturing is the primary driver. The others are carnoSyn® beta-alanine royalties, licensing and raw materials.

Who are Natural Alternatives International's main competitors?

Broad incumbents on record are Catalent and Lonza Group. Direct peers are Glanbia Nutritionals, NOW Foods, Standard Process, NutraScience Labs, TSI Group and Vitakem. Herbalife is listed as an others. Thorne HealthTech is listed as an emerging player.

Does Natural Alternatives International have an API?

No public API is recorded for Natural Alternatives International.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Defense WorldNatural Alternatives International (NASDAQ:NAII) Shares Cross Below 200 Day Moving Average – What’s Next?Natural Alternatives International shares fell below their 200-day moving average on Tuesday, trading at $1.33 against a $2.36 average. Weiss Ratings upgraded the stock from a sell (e+) to a sell (d-), and the company reported a Q2 loss of $0.52 per share on $34.51 million revenue. Integrated Wealth Concepts raised its stake by 267.4% in the quarter.Ticker ReportNatural Alternatives International, Inc. (NASDAQ:NAII) Short Interest UpdateShort interest in Natural Alternatives International rose 79.6% to 13,142 shares as of September 15th. The stock traded down $0.23 to $1.47, and the company reported a quarterly loss of $0.52 per share on $34.51 million revenue. Analysts have a consensus "Sell" rating.American Banking and Market NewsNatural Alternatives International (NASDAQ:NAII) Posts Quarterly Earnings ResultsNatural Alternatives International reported a quarterly loss of $0.52 per share, with a negative return on equity of 12.21% and a net margin of 10.13%. The stock opened at $1.70, and Weiss Ratings reaffirmed a sell rating, leaving the company with an average analyst rating of sell.YahooNatural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD ResultsNatural Alternatives International reported a Q4 fiscal 2026 net loss of $13.5 million on $34.5 million in sales, with a $10.4 million impairment charge for its Carlsbad facility. Fiscal 2026 net loss was $20.7 million, excluding the charge. The company plans to consolidate operations into its Vista facility and explore strategic alternatives.FinancialContent Business PageNatural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD ResultsNatural Alternatives International reported a Q4 fiscal 2026 net loss of $13.5 million on sales of $34.5 million, down from $7.2 million loss in the prior year. The loss included a $10.4 million impairment charge for its Carlsbad facility, and the company plans to consolidate operations into its Vista facility and explore strategic alternatives.Stock TitanNatural Alternatives International posts $13.5M Q4 lossNatural Alternatives International reported a Q4 fiscal 2026 net loss of $13.5 million on sales of $34.5 million, down from a $7.2 million loss a year earlier. Gross margin fell to 5.0% from 10.4%, and the company plans to consolidate its USA manufacturing into its Vista, CA facility.The future of tradingNatural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD ResultsNatural Alternatives International reported a Q4 fiscal 2026 net loss of $13.5 million on $34.5 million in sales, with a $10.4 million impairment charge on its Carlsbad facility. Fiscal 2026 net loss was $20.7 million, and the company plans to consolidate operations into its Vista facility and explore strategic alternatives.TradingViewNatural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD ResultsNatural Alternatives International reported a Q4 fiscal 2026 net loss of $13.5 million, or $2.23 per diluted share, on net sales of $34.5 million. The loss included a $10.4 million non-cash impairment charge for its Carlsbad, CA manufacturing facility. The company plans to consolidate operations into its Vista, CA facility and explore strategic alternatives.TradingViewNatural Alternatives International, Inc. (NAII) Posts Q4 Loss; Takes $10.4M ImpairmentNatural Alternatives International reported a Q4 FY26 net loss of $13.5M on $34.5M sales, including a $10.4M non-cash impairment. The company plans to consolidate U.S. manufacturing into Vista, CA and is exploring strategic alternatives. FY26 net loss was $20.7M, up from $13.6M.Ticker ReportNatural Alternatives International, Inc. (NASDAQ:NAII) Short Interest Down 70.6% in AugustShort interest in Natural Alternatives International fell 70.6% to 7,317 shares as of August 31st. The stock traded down $0.06 to $1.96, and analysts have a consensus sell rating. Institutional investors own 32.40% of the stock.